Panacos Pharmaceuticals (PANC) Financial Statements
Panacos Pharmaceuticals Financial Overview
Panacos Pharmaceuticals's market cap is currently $54. The company's EPS TTM is ―; its P/E ratio is 0.00; Panacos Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 07 | Dec 06 | Dec 05 | Dec 04 | Dec 03 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | ― | ― | ― | ― | ― |
| Operating Income | $ -39.02M | $ -41.70M | $ -40.57M | $ -18.06M | $ -22.13M |
| EBITDA | $ -38.23M | $ -40.94M | $ -39.94M | $ -17.09M | $ -21.07M |
| Net Income | $ -37.46M | $ -38.11M | $ -59.08M | $ -18.16M | $ -22.35M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 55.71M | $ 65.65M | $ 91.57M | $ 6.33M | $ 17.66M |
| Total Debt | $ 19.31M | $ 361.00K | $ 213.00K | $ 164.00K | $ 0.00 |
| Net Debt | $ -32.58M | $ -60.41M | $ -86.92M | $ -4.71M | $ -4.26M |
| Total Liabilities | $ 26.84M | $ 6.97M | $ 5.97M | $ 32.78M | $ 5.41M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -31.08M | $ -30.15M | $ -21.80M | $ -13.15M | $ -21.30M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD